2m 2m 2m 2m 2m 2m 2m
AURA BIOSCIS (AURA)
NASDAQ
$6.97-$0.04 (-0.50%)
Price as of Jul 13, 2026 6:18 PM EDT- $707.5MMarket Cap
- 3.70%1-Year Change
- BiotechnologyIndustry
AURA BIOSCIS (AURA)
$6.97-$0.04 (-0.50%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | 112.8M +17.35% | 96.1M +13.09% | 85.0M +40.96% | 60.3M +71.05% | |
Gross Profit | -112.8M +17.35% | -96.1M +13.09% | -85.0M +40.96% | -60.3M +71.05% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -90.3M +23.19% | -73.3M +12.37% | -65.2M +54.44% | -42.2M +67.87% | |
Depreciation and Amortization Expense | 1.1M -7.69% | 1.2M -5.56% | 1.3M +10.03% | 1.2M +41.64% | |
Total Operating Expenses | 135.3M +13.75% | 118.9M +13.54% | 104.8M +33.69% | 78.4M +72.81% | |
Operating Profit | -112.8M +17.35% | -96.1M +13.09% | -85.0M +40.96% | -60.3M +71.05% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | -9,000 N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 +100.00% | -9,000 N/A | |
Total Nonoperating Income and Expense | 6.7M -27.94% | 9.3M +6.75% | 8.7M +469.19% | 1.5M +153,300.00% | |
Income before Taxes | -106.1M +22.21% | -86.8M +13.81% | -76.3M +26.50% | -60.3M +71.05% | |
Income Taxes | 108,000 -3.57% | 112,000 -18.25% | 137,000 N/A | 0 N/A | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | -106.2M +22.17% | -86.9M +13.76% | -76.4M +30.03% | -58.8M +66.70% | |
Net Income from Continuing Operations Applicable to Common | -106.1M +22.21% | -86.8M +13.81% | -76.3M +29.79% | -58.8M +66.70% | |
Basic EPS and Net Income | -1.76 +0.57% | -1.75 -9.33% | -1.93 -1.53% | -1.96 -78.10% | |
Diluted EPS and Net Income | -1.76 +0.57% | -1.75 -9.33% | -1.93 -1.53% | -1.96 -78.10% | |
Basic Weighted Average Shares | 60.3M +21.52% | 49.7M +25.32% | 39.6M +32.34% | 29.9M +480.18% | |
Diluted Weighted Average Shares | 60.3M +21.52% | 49.7M +25.32% | 39.6M +32.34% | 29.9M +480.18% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 59.5M +87.79% | 31.7M -22.82% | 41.1M -66.23% | 121.6M -18.44% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 59.5M +87.79% | 31.7M -22.82% | 41.1M -66.23% | 121.6M -18.44% | |
Total Current Assets | 149.7M -6.78% | 160.6M -30.70% | 231.8M +17.84% | 196.7M +27.97% | |
Accumulated Depreciation | 7.1M +17.81% | 6.0M +18.86% | 5.0M +30.33% | 3.9M +39.80% | |
Property and Plant and Equipment and Net | 2.6M -18.38% | 3.2M +2.06% | 3.1M -41.35% | 5.4M +2.29% | |
Total Long-Term Assets | 471,000 -9.07% | 518,000 +1.77% | 509,000 +20.33% | 423,000 -91.94% | |
Total Assets | 169.4M -7.16% | 182.5M -28.45% | 255.1M +13.91% | 223.9M +39.93% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 18.4M +23.27% | 14.9M +20.68% | 12.4M +18.17% | 10.5M +43.80% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 14.1M -9.51% | 15.6M -7.41% | 16.9M -5.73% | 17.9M +4,762.77% | |
Total Liabilities | 32.5M +6.50% | 30.5M +4.47% | 29.2M +3.09% | 28.4M +267.49% | |
Retained Earnings | -480.4M +28.38% | -374.2M +30.25% | -287.3M +36.23% | -210.9M +38.63% | |
Total Stockholders Equity | 136.9M -9.91% | 152.0M -32.71% | 225.8M +15.47% | 195.6M +28.41% | |
Total Shares Outstanding | 63.6M +27.18% | 50.0M +1.31% | 49.4M +30.65% | 37.8M +29.30% | |
Cash Flow | |||||
Cash from Operating Activities | -84.7M +6.19% | -79.8M +24.99% | -63.8M +16.93% | -54.6M +68.47% | |
Capital Expenditures | 447,000 -64.33% | 1.3M +76.73% | 709,000 -35.19% | 1.1M -48.52% | |
Cash from Investing Activities | 35.6M -48.28% | 68.8M +160.39% | -114.0M +67.92% | -67.9M +3,093.84% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 77.2M +4,737.30% | 1.6M -98.36% | 97.3M +1.74% | 95.6M -42.48% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -60.35% +51.90% | -39.73% +24.53% | -31.90% +4.23% | -30.61% N/A | |
Return on Equity | -73.52% +59.78% | -46.01% +26.89% | -36.26% +7.34% | -33.78% N/A | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 8.15 -24.37% | 10.77 -42.58% | 18.76 -0.28% | 18.81 N/A | |
Cash Ratio | 3.24 +52.34% | 2.13 -36.05% | 3.32 -71.42% | 11.63 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow